# GPC3-Targeted PET/CT in Hepatocellular Carcinoma

> **NCT07677774** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 40 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Glypican-3
- GPC3-targeted PET/CT

## Interventions

- **DIAGNOSTIC_TEST:** GPC3-targeted PET/CT

## Key facts

- **NCT ID:** NCT07677774
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677774, "GPC3-Targeted PET/CT in Hepatocellular Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*